School of Graduate, Wuhan Sport University, Wuhan, 430079, People's Republic of China.
School of Sports Medicine, Wuhan Sport University, Wuhan, 430079, People's Republic of China.
Clin Interv Aging. 2024 Aug 8;19:1407-1422. doi: 10.2147/CIA.S473083. eCollection 2024.
With the increasingly severe situation of obesity and population aging, there is growing concern about sarcopenia obesity (SO). SO refers to the coexistence of obesity and sarcopenia, which imposes a heavier burden on individuals and society compared to obesity or sarcopenia alone. Therefore, comprehending the pathogenesis of SO and implementing effective clinical interventions are vital for its prevention and treatment. This review uses a comprehensive literature search and analysis of PubMed, Web of Science, and CNKI databases, with search terms including "Sarcopenic obesity", "exercise", "cytokines", "inflammation", "mitochondrial quality control", and "microRNA", covering relevant studies published up to July 2024. The results indicate that the pathogenesis of SO is complex, involving mechanisms like age-related changes in body composition, hormonal alterations, inflammation, mitochondrial dysfunction, and genetic and epigenetic factors. Regarding exercise interventions for SO, aerobic exercise can reduce fat mass, resistance exercise can increase skeletal muscle mass and strength, and combined exercise can achieve both, making it the optimal intervention for SO. The potential mechanisms by which exercise may prevent and treat SO include regulating cytokine secretion, inhibiting inflammatory pathways, improving mitochondrial quality, and mediating microRNA expression. This review emphasizes the effectiveness of exercise interventions in mitigating sarcopenic obesity through comprehensive analysis of its multifactorial pathogenesis and the mechanistic insights into exercise's therapeutic effects. Understanding these mechanisms informs targeted therapeutic strategies aimed at alleviating the societal and individual burdens associated with SO.
随着肥胖和人口老龄化问题的日益严重,人们越来越关注肌少症性肥胖(SO)。SO 是指肥胖和肌少症同时存在,与单独的肥胖或肌少症相比,对个人和社会造成了更沉重的负担。因此,了解 SO 的发病机制并实施有效的临床干预措施对于预防和治疗 SO 至关重要。本综述采用全面的文献检索,并对 PubMed、Web of Science 和 CNKI 数据库进行分析,检索词包括“肌少症性肥胖”、“运动”、“细胞因子”、“炎症”、“线粒体质量控制”和“microRNA”,涵盖截至 2024 年 7 月发表的相关研究。结果表明,SO 的发病机制复杂,涉及与年龄相关的身体成分变化、激素改变、炎症、线粒体功能障碍以及遗传和表观遗传因素等机制。关于 SO 的运动干预,有氧运动可以减少脂肪量,抗阻运动可以增加骨骼肌量和力量,而结合运动则可以两者兼得,是 SO 的最佳干预措施。运动预防和治疗 SO 的潜在机制包括调节细胞因子分泌、抑制炎症途径、改善线粒体质量和调节 microRNA 表达。本综述通过对 SO 多因素发病机制的全面分析以及对运动治疗效果的机制理解,强调了运动干预在减轻肌少症性肥胖方面的有效性。了解这些机制为缓解 SO 给社会和个人带来的负担提供了针对性的治疗策略。
Curr Protein Pept Sci. 2018
Nutrients. 2018-5-12
J Cachexia Sarcopenia Muscle. 2025
Healthcare (Basel). 2025-1-27
Front Endocrinol (Lausanne). 2024-10-14
Int J Environ Res Public Health. 2024-6-1
Obes Rev. 2024-6
Nat Rev Endocrinol. 2024-5
J Gerontol A Biol Sci Med Sci. 2024-4-1
Int J Mol Sci. 2023-7-1